Risk factors for bleeding in hepatocellular adenoma

被引:74
作者
Bieze, M. [1 ]
Phoa, S. S. K. S. [2 ]
Verheij, J. [3 ]
van Lienden, K. P. [4 ]
van Gulik, T. M. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Intervent Radiol, NL-1105 AZ Amsterdam, Netherlands
关键词
MCGILL PAIN QUESTIONNAIRE; FOCAL NODULAR HYPERPLASIA; BENIGN HEPATIC-TUMORS; MALIGNANT-TRANSFORMATION; LIVER;
D O I
10.1002/bjs.9493
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hepatocellular adenoma (HCA) is a benign hepatic lesion that may be complicated by bleeding, although the risk of bleeding is ill-defined. The aim of this study was to assess risk factors for bleeding in patients diagnosed with HCA. Methods: Patients with HCA were included prospectively from January 2008 to July 2012. Patient characteristics were noted. Patients underwent dynamic magnetic resonance imaging (MRI) and/or computed tomography (CT) at presentation and during follow-up. Lesion characteristics on (follow-up) imaging were noted, and bleeding was graded as intratumoral (grade I), intrahepatic (grade II) or extrahepatic (grade III). The standard of reference for diagnosis was histopathology, or dynamic MRI and/or CT findings. Possible risk factors were included if mentioned in literature (lesion size, body mass index), or based on clinical experience (lesion location, visible vessels on imaging). Results: A total of 45 patients (median age 39 (range 22-60) years; 44 women) with 195 lesions (median size 24 (10-250) mm) were evaluated. Bleeding occurred in 29 patients (64 per cent) and in 42 lesions (21.5 per cent) with a median size of 62 (10-160) mm. Size was a risk factor for bleeding (P<0.001), with an increased number of bleeding events in lesions of 35mm or more. Exophytic lesions (protruding from liver) had more bleeding (16 of 24, 67 per cent) than intrahepatic (9 of 82, 11 per cent) or subcapsular (17 of 89, 19 per cent) lesions (P < 0.001). Lesions in segments II and III had more bleeds than those in the right liver (11 of 32 versus 31 of 163; P = 0.049), as did lesions in which peripheral or central arteries were visualized on imaging (10 of 13 versus 32 of 182 lesions with no visible vascularization; P < 0.001). Conclusion: Risk factors for bleeding of HCA include diameter of 35mm or more, visualization of lesional arteries, location in the left lateral liver, and exophytic growth.
引用
收藏
页码:847 / 855
页数:9
相关论文
共 17 条
  • [1] BAUM JK, 1973, LANCET, V2, P926
  • [2] RESECTION OF PRESUMED BENIGN LIVER-TUMORS
    BELGHITI, J
    PATERON, D
    PANIS, Y
    VILGRAIN, V
    FLEJOU, JF
    BENHAMOU, JP
    FEKETE, F
    [J]. BRITISH JOURNAL OF SURGERY, 1993, 80 (03) : 380 - 383
  • [3] Diagnostic Accuracy of MRI in Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia: Prospective Study of the Additional Value of Gadoxetate Disodium
    Bieze, Matthanja
    van den Esschert, Jacomina W.
    Nio, C. Yung
    Verheij, Joanne
    Reitsma, Johannes B.
    Terpstra, Valeska
    van Gulik, Thomas M.
    Phoa, Saffire S. K. S.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (01) : 26 - 34
  • [4] Revisiting the Pathology of Resected Benign Hepatocellular Nodules Using New Immunohistochemical Markers
    Bioulac-Sage, Paulette
    Cubel, Gaelle
    Balabaud, Charles
    Zucman-Rossi, Jessica
    [J]. SEMINARS IN LIVER DISEASE, 2011, 31 (01) : 91 - 103
  • [5] Hepatocellular Adenoma Management and Phenotypic Classification: the Bordeaux Experience
    Bioulac-Sage, Paulette
    Laumonier, Herve
    Couchy, Gabrielle
    Le Bail, Brigitte
    Cunha, Antonio Sa
    Rullier, Anne
    Laurent, Christophe
    Blanc, Jean-Frederic
    Cubel, Gaelle
    Trillaud, Herve
    Zucman-Rossi, Jessica
    Balabaud, Charles
    Saric, Jean
    [J]. HEPATOLOGY, 2009, 50 (02) : 481 - 489
  • [6] A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas
    Dokmak, Safi
    Paradis, Valerie
    Vilgrain, Valerie
    Sauvanet, Alain
    Farges, Olivier
    Valla, Dominique
    Bedossa, Pierre
    Belghiti, Jacques
    [J]. GASTROENTEROLOGY, 2009, 137 (05) : 1698 - 1705
  • [7] FOSTER JH, 1994, ARCH SURG-CHICAGO, V129, P712
  • [8] How Normal Is the Liver in Which the Inflammatory Type Hepatocellular Adenoma Develops?
    Han, Jing
    van den Heuvel, Marius C.
    Kusano, Hironori
    de Jong, Koert P.
    Gouw, Andannette S. H.
    [J]. INTERNATIONAL JOURNAL OF HEPATOLOGY, 2012, 2012
  • [9] Hormonal contraceptive use among women with liver tumors: a systematic review
    Kapp, Nathalie
    Curtis, Kathryn M.
    [J]. CONTRACEPTION, 2009, 80 (04) : 387 - 390
  • [10] MCGILL PAIN QUESTIONNAIRE - MAJOR PROPERTIES AND SCORING METHODS
    MELZACK, R
    [J]. PAIN, 1975, 1 (03) : 277 - 299